NF-κB is activated in the stem cells of MDS patients, leading to impaired function of hematopoietic stem and progenitor cells, which is associated with increased ferritin levels, increased proportion of primitive cells, increased IL-8 levels, and inflammatory microenvironments (20). This evidence concerns the gene NFKB1 and myelodysplastic syndrome.